NCT01915667 - Oral Bioavailability of Two Solid Formulations of GLPG0634 | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

September 30, 2013

Study Completion Date

September 30, 2013

Conditions

Healthy

Interventions

DRUG

200 mg GLPG0634 as capsules, fasted

single oral dose of 200 mg GLPG0634 given as capsules in fasted condition

DRUG

200 mg GLPG0634 as tablets, fasted

single oral dose of 200 mg GLPG0634 given as tablets in fasted condition

DRUG

200 mg GLPG0634 as tablets, fed

single oral dose of 200 mg GLPG0634 given as tablets in fed condition

Trial Locations (1)

SGS LSS Clinical Pharmacology Unit Antwerp, Antwerp